hepatitis-b

Documents about hepatitis-b

• Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B#827618ClinicalTrials.gov
• Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)#828057ClinicalTrials.gov
• Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver#901731ClinicalTrials.gov
• A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B#968297ClinicalTrials.gov
• Estudio de prevalencia de hepatitis B y C en personal de las Fuerzas Armadas del Ecuador.#431561Repositorio Digital USFQ
• Natural History of Post-transfusion Non-A, Non-B Hepatitis#883050ClinicalTrials.gov
• Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B#810452ClinicalTrials.gov
• ID HBV Vaccination With Imiquimod in OBI#238186ClinicalTrials.gov
• Characterization of Clonal B Cell Populations in HCV Infection#855540ClinicalTrials.gov
• Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase#805637ClinicalTrials.gov
• A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B#828418ClinicalTrials.gov
• A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors#839361ClinicalTrials.gov
• A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)#867456ClinicalTrials.gov
• Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB#1033354ClinicalTrials.gov
• Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants#125922ClinicalTrials.gov
• Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.#160170ClinicalTrials.gov
• Evaluation of an Infant Immunization Encouragement Program in Nigeria#287374ClinicalTrials.gov
• Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents#290835ClinicalTrials.gov
• Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine#405194ClinicalTrials.gov
• Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).#454065ClinicalTrials.gov
• Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong#379072PLOS
• ddOTs: A multiplexed quantitative ddPCR approach for resolving overlapping hepatitis B virus transcripts to decipher cccDNA-driven transcription#416088PLOS
• Natural products targeting hepatitis B virus X protein and HBx-associated pathways in HBV-related hepatocellular carcinoma: mechanisms and therapeutic potential#784675Europe PMC
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis#853429ClinicalTrials.gov
• Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured#865676ClinicalTrials.gov
• Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients#967386ClinicalTrials.gov
• Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine#160189ClinicalTrials.gov
• Response to Hepatitis B Vaccine in Celiac Disease Patients#238171ClinicalTrials.gov
• Stochastic Dynamics of Hepatitis B Virus Infection: Extinction, Persistence, and Ergodicity#627863arXiv (OAI Expanded)
• Stochastic Dynamics of Hepatitis B Virus Infection: Extinction, Persistence, and Ergodicity#629725arXiv (All)
• Biomarkers Guided Stopping NAs Treatment#827455ClinicalTrials.gov
• Drug Drug Interaction Study for EYP001 With Entecavir#891128ClinicalTrials.gov
• Protectivity and Safety Following Recombinant Hepatitis B Vaccine#995384ClinicalTrials.gov
• Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum#835214ClinicalTrials.gov
• Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)#849377ClinicalTrials.gov
• A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial#854440ClinicalTrials.gov
• Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis#872582ClinicalTrials.gov
• Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D)#301132HAL (France)
• A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis#836548ClinicalTrials.gov
• Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m#847212ClinicalTrials.gov
• Case-control study of risk factors for abscess development following hepatitis B vaccination in children in Timor-Leste, 2024#302065PLOS
• Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B#828421ClinicalTrials.gov
• Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF#894313ClinicalTrials.gov
• A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.#904651ClinicalTrials.gov
• Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon#1009407ClinicalTrials.gov
• B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B#67676ClinicalTrials.gov
• Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis#125962ClinicalTrials.gov
• Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y#444760ClinicalTrials.gov
• Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y#454079ClinicalTrials.gov
• Primary liver cancer at tertiary healthcare facility in Guinea: a cross-sectional study#284225HAL (France)